These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 26567194)

  • 1. Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancer.
    Jump DB; Depner CM; Tripathy S; Lytle KA
    Adv Nutr; 2015 Nov; 6(6):694-702. PubMed ID: 26567194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipidomic and transcriptomic analysis of western diet-induced nonalcoholic steatohepatitis (NASH) in female Ldlr -/- mice.
    Garcia-Jaramillo M; Spooner MH; Löhr CV; Wong CP; Zhang W; Jump DB
    PLoS One; 2019; 14(4):e0214387. PubMed ID: 30943218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis.
    Depner CM; Philbrick KA; Jump DB
    J Nutr; 2013 Mar; 143(3):315-23. PubMed ID: 23303872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A metabolomic analysis of omega-3 fatty acid-mediated attenuation of western diet-induced nonalcoholic steatohepatitis in LDLR-/- mice.
    Depner CM; Traber MG; Bobe G; Kensicki E; Bohren KM; Milne G; Jump DB
    PLoS One; 2013; 8(12):e83756. PubMed ID: 24358308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.
    Lytle KA; Wong CP; Jump DB
    PLoS One; 2017; 12(4):e0173376. PubMed ID: 28422962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?
    Lytle KA; Jump DB
    PLoS One; 2016; 11(1):e0146942. PubMed ID: 26761430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr-/- mice.
    Jump DB; Depner CM; Tripathy S; Lytle KA
    Proc Nutr Soc; 2016 Feb; 75(1):1-9. PubMed ID: 26282529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic Steatohepatitis and HCC in a Hyperphagic Mouse Accelerated by Western Diet.
    Ganguly S; Muench GA; Shang L; Rosenthal SB; Rahman G; Wang R; Wang Y; Kwon HC; Diomino AM; Kisseleva T; Soorosh P; Hosseini M; Knight R; Schnabl B; Brenner DA; Dhar D
    Cell Mol Gastroenterol Hepatol; 2021; 12(3):891-920. PubMed ID: 34062281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Harris SE; Poolman TM; Arvaniti A; Cox RD; Gathercole LL; Tomlinson JW
    Am J Physiol Gastrointest Liver Physiol; 2020 Sep; 319(3):G345-G360. PubMed ID: 32755310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Lipidomic Analysis of Docosahexaenoic Acid (22:6, ω3) Mediated Attenuation of Western Diet Induced Nonalcoholic Steatohepatitis in Male
    García-Jaramillo M; Lytle KA; Spooner MH; Jump DB
    Metabolites; 2019 Oct; 9(11):. PubMed ID: 31661783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A structurally engineered fatty acid, icosabutate, suppresses liver inflammation and fibrosis in NASH.
    Fraser DA; Wang X; Lund J; Nikolić N; Iruarrizaga-Lejarreta M; Skjaeret T; Alonso C; Kastelein JJP; Rustan AC; Kim YO; Schuppan D
    J Hepatol; 2022 Apr; 76(4):800-811. PubMed ID: 34915054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.
    Suzuki-Kemuriyama N; Matsuzaka T; Kuba M; Ohno H; Han SI; Takeuchi Y; Isaka M; Kobayashi K; Iwasaki H; Yatoh S; Suzuki H; Miyajima K; Nakae D; Yahagi N; Nakagawa Y; Sone H; Yamada N; Shimano H
    PLoS One; 2016; 11(6):e0157580. PubMed ID: 27333187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential treatment of human nonalcoholic fatty liver disease with long-chain omega-3 polyunsaturated fatty acids.
    Bouzianas DG; Bouziana SD; Hatzitolios AI
    Nutr Rev; 2013 Nov; 71(11):753-71. PubMed ID: 24148001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Nonalcoholic Fatty Liver Disease with Long-Chain n-3 Polyunsaturated Fatty Acids in Humans.
    Kelley NS
    Metab Syndr Relat Disord; 2016 Nov; 14(9):417-430. PubMed ID: 27710160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omega-3 fatty acids and nonalcoholic fatty liver disease in adults and children: where do we stand?
    Spooner MH; Jump DB
    Curr Opin Clin Nutr Metab Care; 2019 Mar; 22(2):103-110. PubMed ID: 30601174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review.
    Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB
    Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the Co-Administration of N-3 Fatty Acids and Olive Oil Components in Preclinical Nonalcoholic Fatty Liver Disease Models: A Mechanistic View.
    Valenzuela R; Videla LA
    Nutrients; 2020 Feb; 12(2):. PubMed ID: 32075238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr-/- mice by targeting the TGFβ-Smad3 pathway.
    Lytle KA; Depner CM; Wong CP; Jump DB
    J Lipid Res; 2015 Oct; 56(10):1936-46. PubMed ID: 26315048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking integrin α
    Rai RP; Liu Y; Iyer SS; Liu S; Gupta B; Desai C; Kumar P; Smith T; Singhi AD; Nusrat A; Parkos CA; Monga SP; Czaja MJ; Anania FA; Raeman R
    J Hepatol; 2020 Nov; 73(5):1013-1022. PubMed ID: 32540177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course of western diet (WD) induced nonalcoholic steatohepatitis (NASH) in female and male Ldlr-/- mice.
    Spooner MH; Garcia-Jaramillo M; Apperson KD; Löhr CV; Jump DB
    PLoS One; 2023; 18(10):e0292432. PubMed ID: 37819925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.